Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mackenzie Financial Corp decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the period. Mackenzie […]
Mackenzie Financial Corp cut its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the quarter. Mackenzie Financial […]
Mackenzie Financial Corp decreased its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 9.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 942,657 shares of the health services provider’s stock after selling 98,923 shares during the quarter. Mackenzie […]
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report released on Monday. The brokerage issued a buy rating on the health services provider’s stock. Several other equities analysts have also recently weighed in on AMED. TD Cowen increased their price target on Amedisys from $84.00 to $101.00 and gave […]
Oppenheimer Asset Management Inc. trimmed its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 1.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,083 shares of the health services provider’s stock after selling 1,195 shares […]